Science ❯ Biotechnology ❯ RNA Interference ❯ Targeted RNAi Molecule

Arrowhead Pharmaceuticals

FDA Clears Arrowhead’s Redemplo for FCS, Marking the Biotech’s First Approval

The quarterly at-home siRNA sets up a U.S. launch this year against Ionis’s pricier Tryngolza.